Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim Analysis
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Buechner, J; Grupp, SA; Maude, SL; Boyer, M; Bittencourt, H; Laetsch, TW; Bader, P; Verneris, MR; Stefanski, H; Myers, GD; Qayed, M; Pulsipher, MA; De Moerloose, B; Hiramatsu, H; Schlis, K; Davis, K; Martin, PL; Nemecek, E; Peters, C; Wood, P; Taran, T; Mueller, KT; Zhang, Y; Rives, S
Published Date
- September 2017
Published In
Volume / Issue
- 17 /
Start / End Page
- S263 - S264
Published By
International Standard Serial Number (ISSN)
- 2152-2650
Digital Object Identifier (DOI)
- 10.1016/j.clml.2017.07.030